Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. - sprookjes - yvandenbroek - TriplyDB

Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology.

Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology.

http://www.wikidata.org/entity/Q40592930

about

MR imaging features of high-grade gliomas in murine models: how they compare with human disease, reflect tumor biology, and play a role in preclinical trials Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas A diffusion-compensated model for the analysis of DCE-MRI data: theory, simulations and experimental results.Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data.Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics.Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.Incorporating a vascular term into a reference region model for the analysis of DCE-MRI data: a simulation study Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging Impact of adjuvant chemotherapy for gliomatosis cerebri Perfusion CT imaging of brain tumors: an overview.ZD6474, a multitargeted inhibitor for receptor tyrosine kinases, suppresses growth of gliomas expressing an epidermal growth factor receptor mutant, EGFRvIII, in the brain Adult human neurogenesis: from microscopy to magnetic resonance imaging Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.A case report of preoperative and postoperative 7.0T brain MRI in a patient with a small cell glioblastoma.Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models.Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model.High-resolution longitudinal screening with magnetic resonance imaging in a murine brain cancer model.Clinical application of 7.0 T magnetic resonance images in Gamma Knife radiosurgery for a patient with brain metastases.Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons.Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model--an MRI study High-field small animal magnetic resonance oncology studies.Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.Establishment of C6 brain glioma models through stereotactic technique for laser interstitial thermotherapy research High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI.An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme MRI for assessing antivascular cancer treatments.Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification.MRI perfusion in determining pseudoprogression in patients with glioblastoma.Mitotic Activity in Glioblastoma Correlates with Estimated Extravascular Extracellular Space Derived from Dynamic Contrast-Enhanced MR Imaging A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.Molecularly targeted therapies for malignant gliomas.Experience with 7.0 T MRI in Patients with Supratentorial Meningiomas Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting.

P2860

Q26863563-988D5469-D5D3-41A7-87C6-09FAF44848FC Q28476714-D97FD886-B44C-44C8-9749-DFEE7D3D7843 Q30596630-BE3A22F8-0E5E-4329-A58A-A14145730747 Q30653828-8B6039D9-FD71-49CA-928F-890010D5C7CD Q30687678-E60CEDCE-84C8-4B20-A664-DCFF7874A7CF Q30870628-57EF9066-F1CC-42F0-B13F-FE2EF29FEC6C Q30984368-6267C846-98BE-4735-8D38-C67DEFFB00F1 Q31153802-17D8EAAC-9CDE-4260-ADE3-57EE11ACE339 Q33525779-3166A2FD-7FAD-4DB5-B074-E1F759927AFB Q33655658-34ACF994-7FFE-4C0F-A63D-979BD59F7437 Q33738599-976FFB40-E33F-4815-8D3E-25FD587B3BD8 Q33870872-796E4326-C739-4A1D-A2F8-14569F9A545C Q33881835-F8AF1DEE-9DBB-479F-9156-77D5BFB92082 Q33904348-3D7E54FA-C2DA-47DF-B0B9-C45B1BAC447F Q33913655-3D148B33-84A3-4577-932B-730E69B7E4DC Q34203953-7A7EF049-8C03-4CAE-B47C-A43FC3BD0ADB Q34480549-B1C4E282-1D70-4704-8AE9-7718D63D41C8 Q34645287-B932F4C9-CFF8-47CF-A7FE-5BE2A4619A10 Q34701110-8FFFBB41-F07A-456A-A209-F75F83C7FB25 Q34773152-CFBF609B-62BB-4DEC-BB11-9529E8A47533 Q35009911-30B36637-08E9-4582-9C3A-4A1C0E99392D Q35068619-54BE56EC-A04B-4A2F-9A5B-1423CA066933 Q35127962-1DFD5E31-AAB1-4465-B287-E7AEF0B9DE34 Q35312455-1E4F7201-4BD0-499A-9887-5B480CC202BA Q35317072-40D610B6-6E25-4C25-9F8A-1D0CC749A763 Q35605002-5340F078-6A52-4813-AACA-664AC0088DBF Q35625666-809C6BC9-E4D5-4068-8785-E5C70A7B116E Q35720477-290E3EA4-94BE-4685-82E0-0408E0293259 Q35770218-D4D4F2AF-DF8F-45A8-886D-4052C66FEA5F Q35905005-AB670FB6-B45A-4855-970D-5D244996D8BB Q36048224-E6F564A0-CB58-49CB-B84B-8E79786DFD64 Q36231584-0D72CE5C-87BC-49DA-9AD6-065021430499 Q36459981-AD6EF374-87A1-4490-801F-735BAB055748 Q36585386-32DC8FD4-F0FF-4149-9C77-D4FFF27FF251 Q36755234-B877E4AE-384A-4AB7-9215-C030569BA5CF Q36893250-545E4BC3-182B-4FB1-8234-2C291C9A2645 Q37107374-94EF1068-5157-4940-9843-8B079987346F Q37112593-257F8B8A-3983-4433-984D-E405AF5251BD Q37233933-D21D5832-55B2-445A-8F3F-AC6BFB24321B Q37340951-430BECAF-5D77-4F46-A71A-AAC71152945E

P2860

Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology.

http://www.wikidata.org/entity/Q40592930

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Dynamic, contrast-enhanced per ...... rrelation with histopathology.

@en

type

label

Dynamic, contrast-enhanced per ...... rrelation with histopathology.

@en

prefLabel

Dynamic, contrast-enhanced per ...... rrelation with histopathology.

@en

P1433

Q40592930-533F62F5-F31F-407C-8953-026D267BF967

P1476

Q40592930-09609EE6-6329-4644-8DD4-0D291F2E2ED4

P2093

Q40592930-02E1151E-A5F9-4004-AF67-35E6E6792B7B

Q40592930-39830E07-14AB-457D-8608-E624BF367B59

Q40592930-878CB74E-5FDB-4DDB-8E0F-2A35088346BD

Q40592930-EA35A4D7-835F-45DC-90E4-37981574E122

Q40592930-FE8722BB-E8F8-46A9-9BA4-DD3E81C6779D

P304

Q40592930-EE8516A1-0372-44E4-A6D1-9DE70DD5CE86

P31

Q40592930-002B40C6-B125-4448-A9D7-A1387CEF8A7A

P356

Q40592930-724B50A8-A71D-473B-82E1-921951C092D3

P433

Q40592930-6E742415-5E64-4D3C-A43B-59476EBB74C4

P478

Q40592930-7878BCE2-B60D-48C3-A196-2FB87A17D7DA

P50

Q40592930-5AAF140B-6E95-4A2E-9DEA-6A24EE1A0CE4

Q40592930-D37791A8-8041-44D3-A578-046C58E6F8F1

P577

Q40592930-85052F51-ED21-4C85-9377-6249D05DEAFC

P5875

Q40592930-E67C6FE0-CDC8-49AB-B56C-4912A004D9F2

P698

Q40592930-B8E7B13D-FB00-414E-BDC9-7D846D968592

P356

P1433

Magnetic Resonance in Medicine

P1476

Dynamic, contrast-enhanced per ...... rrelation with histopathology.

@en

P2093

Daniel H Turnbull

http://www.w3.org/2001/XMLSchema#string

David Zagzag

http://www.w3.org/2001/XMLSchema#string

Jim Babb

http://www.w3.org/2001/XMLSchema#string

Olivier Jin

http://www.w3.org/2001/XMLSchema#string

Soonmee Cha

http://www.w3.org/2001/XMLSchema#string

P304

848-855

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MRM.10446

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Youssef Wadghiri

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10795864

http://www.w3.org/2001/XMLSchema#string

P698

12704767

http://www.w3.org/2001/XMLSchema#string